Join us as we Commemorate HIV Vaccine Awareness Day ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

View this email in your browser ([link removed])
[link removed] May 13, 2024


** HIV Vaccine Awareness Day, May 18
------------------------------------------------------------

Dear Advocate,

As we prepare to commemorate HIV Vaccine Awareness Day ([link removed]) (HVAD) on May 18, the field continues to see some modest scientific breakthroughs, while still facing extraordinary challenges. Despite having an evolving toolbox of highly effective prevention options including new long-acting PrEP, we continue to see high HIV incidence in hard-hit corners of the world. Many advocates and researchers agree that ending the HIV epidemic globally without a vaccine will be extremely difficult—even with long-acting PrEP products on the market and more on the way.
"This toolbox of PrEP options will hopefully be transformative, but it is critically important that we still prioritize a vaccine." – Nina Russell, Director of TB and HIV R&D, the Bill & Melinda Gates Foundation on the new PxPulse podcast

Scroll through our list below for an exciting new podcast, HVAD webinars, and other key resources to mark HVAD 2024.
HVAD Collection of Resources and Events

Podcasts
New Episode!
[link removed]


** An HIV Vaccine: Looking into the future with Nina Russell ([link removed])
------------------------------------------------------------

In our new PxPulse ([link removed]) episode, Nina Russell of the Bill & Melinda Gates Foundation talks about where she sees promise in the science, the goals for an HIV vaccine, and why it has an essential role to play alongside the scale up of PrEP.

And to round out your vaccine knowledge, listen to these two archived PxPulse podcasts: Evolving Strategies for an HIV Vaccine: In conversation with Katy Stephenson ([link removed]) , and Research Fundamentals: An HIV Vaccine — What’s the challenge and what’s the science? ([link removed]) .
l ([link removed]) isten now [link removed]
Webinar
May 16, 2024 @ 9.00am ET
[link removed]


** Just What is Discovery Medicine? And What Does it Mean for HIV Vaccine Research? ([link removed])
------------------------------------------------------------

Join the Choice Agenda to gain a broad understanding of the current landscape for HIV vaccines and what discovery medicine ([link removed]) means for HIV vaccine research and development moving forward, with a focus on community and advocacy priorities.
Register Now ([link removed]) [link removed]
Webinar
June 3, 2024 @ 9.00am ET
[link removed]


** From the Lab to the Jab: Lessons learned and what’s next in HIV vaccine research ([link removed])
------------------------------------------------------------

AVAC’s issue briefs, From the Lab to the Jab ([link removed]) , cover the barriers to, and solutions for equitable access to vaccines in low- and middle-income countries. During this webinar, an expert panel will discuss lessons learned, an international initiative for vaccine development, and how research and access can be improved.
Register Now ([link removed]) [link removed]
Partner Events

Communities across the globe are engaging in a wide array of events focused on HIV vaccine awareness. See our HVAD page ([link removed]) for details on local and regional activities the Coalition to Accelerate & Support Prevention Research (CASPR) ([link removed]) partners are leading.

Register for our partner, IAVI's webinar: Mapping Routes to Success in HIV Vaccine Development ([link removed]) , on May 29, which will focus on strategies to advance the most promising HIV vaccine candidates toward clinical trials, emphasizing the shift toward localized research and development. It will also delve into the progression of experimental medicines, including germline targeting and other innovative approaches, from initial trials to gaining regulatory approval and community acceptance.
Learn More > ([link removed])
infographic
[link removed]

20 years and 12 efficacy trials have delivered two positive signals for vaccines and bNAbs, but unfortunately many more flat results. This infographic provides this historical timeline and key information about each trial.
d ([link removed]) ownload [link removed]

And, on the heels of last week’s HIV Vaccine Trials Network (HVTN) annual meeting, where much discussion surrounded the potential of role of bNAbs in prevention (see AVAC’s 2023 HVAD spotlight on bNABs ([link removed]) ) be sure to watch this space for more resources that unpack it all.

Best,

AVAC
Follow us @hivpxresearch ([link removed])
[link removed] [link removed] [link removed]
Share this issue ([link removed]) [link removed]
AVAC Global Advocacy for HIV Prevention
+1 212 796 6423 [email protected] (mailto:[email protected]) www.avac.org ([link removed])
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences ([link removed]) | Unsubscribe ([link removed])